scispace - formally typeset
R

Rork Kuick

Researcher at University of Michigan

Publications -  166
Citations -  17557

Rork Kuick is an academic researcher from University of Michigan. The author has contributed to research in topics: Gene & Gene expression profiling. The author has an hindex of 60, co-authored 166 publications receiving 16459 citations. Previous affiliations of Rork Kuick include University of Florida.

Papers
More filters
Journal ArticleDOI

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles

TL;DR: The ability of gene expression profiles to classify tumors is demonstrated and determination of organ-specific gene Expression profiles will play a significant role in a wide variety of clinical settings, including molecular diagnosis and classification is suggested.
Journal ArticleDOI

Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion.

TL;DR: Findings support a key role for the HOXC10 homeobox protein in cervical cancer progression and suggest other genes with differential expression in invasive SCC versus HSIL may contribute to tumor progression or may be useful as markers for cancer diagnosis or progression risk.
Journal ArticleDOI

CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia

TL;DR: CDX2 regulates LI-cadherin gene expression in normal, metaplastic, and neoplastic tissues of the gastrointestinal tract via binding to elements in the 5'-flanking region of the gene.
Journal ArticleDOI

Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis

TL;DR: The results suggest that a distinctive serum protein profile involving abundant proteins may be observed in lung cancer patients relative to healthy subjects or patients with chronic disease and may have utility as part of strategies for detecting lung cancer.
Journal ArticleDOI

Preclinical Targeting of the Type I Insulin-Like Growth Factor Receptor in Adrenocortical Carcinoma

TL;DR: Findings establish a critical role of IGF signaling in ACC pathophysiology and provide rationale for use of targeted IGF-1R antagonists to treat adrenocortical carcinoma in future clinical trials.